Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 8Bile Duct Neoplasms 4Pancreatic Neoplasms 3Liver Neoplasms 3Colorectal Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Esophageal Neoplasms 2Barrett Esophagus 2Skin Neoplasms 1Rectal Neoplasms 1Photosensitivity Disorders 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms by Site 1Klatskin Tumor 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Digestive System Diseases 1Constriction, Pathologic 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Diseases 1Bile Duct Diseases 1Adenocarcinoma 1

Interventions

Cisplatin 116Radiotherapy 84Paclitaxel 77Fluorouracil 62Carboplatin 41Drug Therapy 38pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Neoadjuvant Therapy 24toripalimab 23Oxaliplatin 23Radiation 20sintilimab 19camrelizumab 19Esophagectomy 18130-nm albumin-bound paclitaxel 18Capecitabine 17Surgical Procedures, Operative 16Nivolumab 16Leucovorin 15Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10Immune Checkpoint Inhibitors 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Photochemotherapy × Gastrointestinal × Clear all
NCT05386056 2022-11-28

Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

Peking University

Phase 2 Unknown
54 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡